www.biopharma-stocks.com
Open in
urlscan Pro
185.17.252.199
Public Scan
Submitted URL: http://biopharma-stocks.com/
Effective URL: https://www.biopharma-stocks.com/
Submission: On February 01 via manual from AT — Scanned from DE
Effective URL: https://www.biopharma-stocks.com/
Submission: On February 01 via manual from AT — Scanned from DE
Summary
This website contacted 16 IPs
in 4 countries
across 10 domains to perform 108 HTTP transactions.
The main IP is 185.17.252.199, located in
New Zealand and
belongs to SIMPLYTRANSIT, GB.
The main domain is www.biopharma-stocks.com.
TLS certificate: Issued by R3 on December 11th 2021. Valid for: 3 months.
This is the only time www.biopharma-stocks.com was scanned on urlscan.io!
TLS certificate: Issued by R3 on December 11th 2021. Valid for: 3 months.
This is the only time www.biopharma-stocks.com was scanned on urlscan.io!
urlscan.io Verdict: No classification
Domain & IP information
62
185.17.252.199
(New Zealand)
ASN29550 (SIMPLYTRANSIT, GB)
PTR: onehoursitefix.com
ASN29550 (SIMPLYTRANSIT, GB)
PTR: onehoursitefix.com
| biopharma-stocks.com | |
| www.biopharma-stocks.com |
2
2a00:1450:4001:82f::2008
(Frankfurt am Main, Germany)
ASN15169 (GOOGLE, US)
ASN15169 (GOOGLE, US)
| www.googletagmanager.com |
1
184.30.21.80
(Frankfurt am Main, Germany)
ASN16625 (AKAMAI-AS, US)
PTR: a184-30-21-80.deploy.static.akamaitechnologies.com
ASN16625 (AKAMAI-AS, US)
PTR: a184-30-21-80.deploy.static.akamaitechnologies.com
| amplify.outbrain.com |
4
2a00:1450:4001:812::2002
(Frankfurt am Main, Germany)
ASN15169 (GOOGLE, US)
ASN15169 (GOOGLE, US)
| googleads.g.doubleclick.net |
2
2a00:1450:4001:803::2006
(Frankfurt am Main, Germany)
ASN15169 (GOOGLE, US)
ASN15169 (GOOGLE, US)
| static.doubleclick.net |
| Apex Domain Subdomains |
Transfer | |
|---|---|---|
| 62 |
biopharma-stocks.com
1 redirects
biopharma-stocks.com www.biopharma-stocks.com |
5 MB |
| 19 |
youtube.com
www.youtube.com — Cisco Umbrella Rank: 92 |
1 MB |
| 8 |
gstatic.com
fonts.gstatic.com www.gstatic.com |
133 KB |
| 7 |
doubleclick.net
2 redirects
stats.g.doubleclick.net — Cisco Umbrella Rank: 96 googleads.g.doubleclick.net — Cisco Umbrella Rank: 46 static.doubleclick.net — Cisco Umbrella Rank: 356 |
2 KB |
| 3 |
google.com
analytics.google.com — Cisco Umbrella Rank: 1062 www.google.com — Cisco Umbrella Rank: 13 |
27 KB |
| 3 |
outbrain.com
amplify.outbrain.com — Cisco Umbrella Rank: 2353 tr.outbrain.com — Cisco Umbrella Rank: 2115 |
4 KB |
| 2 |
ytimg.com
i.ytimg.com — Cisco Umbrella Rank: 109 |
65 KB |
| 2 |
ggpht.com
yt3.ggpht.com — Cisco Umbrella Rank: 206 |
3 KB |
| 2 |
googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 78 |
95 KB |
| 1 |
google.de
www.google.de — Cisco Umbrella Rank: 5557 |
501 B |
| 108 | 10 |
| Domain | Requested by | |
|---|---|---|
| 61 | www.biopharma-stocks.com |
www.biopharma-stocks.com
|
| 19 | www.youtube.com |
www.biopharma-stocks.com
www.youtube.com |
| 4 | www.gstatic.com |
www.youtube.com
www.gstatic.com |
| 4 | googleads.g.doubleclick.net |
2 redirects
www.youtube.com
|
| 4 | fonts.gstatic.com |
www.biopharma-stocks.com
www.youtube.com |
| 2 | i.ytimg.com |
www.youtube.com
|
| 2 | yt3.ggpht.com |
www.youtube.com
|
| 2 | www.google.com |
www.youtube.com
|
| 2 | static.doubleclick.net |
www.youtube.com
|
| 2 | tr.outbrain.com |
amplify.outbrain.com
www.biopharma-stocks.com |
| 2 | www.googletagmanager.com |
www.biopharma-stocks.com
www.googletagmanager.com |
| 1 | www.google.de |
www.biopharma-stocks.com
|
| 1 | stats.g.doubleclick.net |
www.googletagmanager.com
|
| 1 | analytics.google.com |
www.googletagmanager.com
|
| 1 | amplify.outbrain.com |
www.biopharma-stocks.com
|
| 1 | biopharma-stocks.com | 1 redirects |
| 108 | 16 |
This site contains links to these domains. Also see Links.
| Subject Issuer | Validity | Valid | |
|---|---|---|---|
| www.biopharma-stocks.com R3 |
2021-12-11 - 2022-03-11 |
3 months | crt.sh |
| *.google-analytics.com GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| *.google.com GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| *.gstatic.com GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| *.outbrain.com DigiCert SHA2 Secure Server CA |
2021-05-25 - 2022-06-01 |
a year | crt.sh |
| *.g.doubleclick.net GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| www.google.de GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| *.doubleclick.net GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| www.google.com GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
| *.googleusercontent.com GTS CA 1C3 |
2022-01-10 - 2022-04-04 |
3 months | crt.sh |
| edgestatic.com GTS CA 1C3 |
2021-12-27 - 2022-03-21 |
3 months | crt.sh |
This page contains 3 frames:
Primary Page:
https://www.biopharma-stocks.com/
Frame ID: B9927AAC04BB55C780E0C56823722EA5
Requests: 73 HTTP requests in this frame
Frame:
https://www.youtube.com/embed/Yqekde-I61o?wmode=transparent&autoplay=0
Frame ID: 32BCC5D059024945881F91B110067FAF
Requests: 18 HTTP requests in this frame
Frame:
https://www.youtube.com/embed/Yqekde-I61o?autoplay=0&enablejsapi=1&wmode=opaque
Frame ID: E63CCBAFD0A75703DC91616DF3FEE7B9
Requests: 19 HTTP requests in this frame
Screenshot
Page Title
Biopharma-Stocks.comPage URL History Show full URLs
-
http://biopharma-stocks.com/
HTTP 301
https://www.biopharma-stocks.com/ Page URL
Detected technologies
WordPress
(CMS)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- <link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
- /wp-(?:content|includes)/
Bootstrap
(Web Frameworks)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js
Font Awesome
(Font Scripts)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
Google Analytics
(Analytics)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
Google Tag Manager
(Tag Managers)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- googletagmanager\.com/gtm\.js
- googletagmanager\.com/gtag/js
Lightbox
(JavaScript Libraries)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- lightbox(?:-plus-jquery)?.{0,32}\.js
Modernizr
(JavaScript Libraries)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- ([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js
jQuery
(JavaScript Libraries)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?
jQuery Migrate
(JavaScript Libraries)
Expand
Overall confidence: 100%
Detected patterns
Detected patterns
- jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?
Page Statistics
36 Outgoing links
These are links going to different origins than the main page.
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-inc-der-auf-basis-der-accumtmtechnologie-von-defence-formulierte-hpvimpfstoff-accuvacpt-loest-vergleich-mit-gardasil-eine-mal-hoehere-humorale-immunantwort-aus/?newsID=1507203
Title: Breaking News: Im Vergleich mit Gardasil-9 (Merck) löst HPV-Impfstoff von Defence Therapeutics eine 27- bzw. 36-fache Steigerung des Antikörpertiters nach 4 bzw. 6 Wochen im Anschluss an die Immunisierung aus
Title: Breaking News: Im Vergleich mit Gardasil-9 (Merck) löst HPV-Impfstoff von Defence Therapeutics eine 27- bzw. 36-fache Steigerung des Antikörpertiters nach 4 bzw. 6 Wochen im Anschluss an die Immunisierung aus
Search URL Search Domain Scan URL
URL: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market
Title: Markt für Krebsimmuntherapielösungen derzeit mehr als 100 Milliarden Dollar schwer
Title: Markt für Krebsimmuntherapielösungen derzeit mehr als 100 Milliarden Dollar schwer
Search URL Search Domain Scan URL
URL: https://reportcrux.com/press-release/Biopharma-Market
Title: Wert von fast 250 Milliarden Dollar
Title: Wert von fast 250 Milliarden Dollar
Search URL Search Domain Scan URL
URL: https://www.irw-press.com/de/news/der-auf-basis-der-accumtm-technologie-von-defense-formulierte-hpv-impfstoff-accuvac-pt009-loest-im-vergleich-mit-gardasil-9-eine-36-mal-hoehere-humorale-immunantwort-aus_63860.html?isin=CA24463V1013
Title: eine 27- bzw. 36-fache Steigerung des Antikörpertiters nach 4 bzw. 6 Wochen im Anschluss an die Immunisierung aus
Title: eine 27- bzw. 36-fache Steigerung des Antikörpertiters nach 4 bzw. 6 Wochen im Anschluss an die Immunisierung aus
Search URL Search Domain Scan URL
URL: https://defencetherapeutics.com/accum-technology/
Title: intrazelluläre Akkumulation von verabreichten Medikamenten um das 10-Fache im Vergleich zu aktuellen Antikörper-Wirkstoff-Konjugaten (ADCs)
Title: intrazelluläre Akkumulation von verabreichten Medikamenten um das 10-Fache im Vergleich zu aktuellen Antikörper-Wirkstoff-Konjugaten (ADCs)
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/der-krebsimpfstoff-accuvacd-von-defence-therapeutics-loest-eine-wirksame-langanhaltende-antitumorantwort-aus/?newsID=1448770
Title: In einer präklinischen Studie bestätigte der Krebsimpfstoff AccuVAC-D001 von Defence Therapeutics eine sehr wirksame antitumorale Reaktion, die bei Mäusen eine Heilungsrate von 70 % zeigte.
Title: In einer präklinischen Studie bestätigte der Krebsimpfstoff AccuVAC-D001 von Defence Therapeutics eine sehr wirksame antitumorale Reaktion, die bei Mäusen eine Heilungsrate von 70 % zeigte.
Search URL Search Domain Scan URL
URL: https://www.pharmiweb.com/press-release/2021-07-06/the-antibody-response-induced-by-defence-therapeutics-accuvac-pt001-vaccine-cross-reacts-with-all-te
Title: Kreuzreaktion mit dem Spike-Protein in allen getesteten Varianten des COVID-19-Virus gezeigt und besonders wirksame Ergebnisse gegen die hochansteckende Delta-Variante gezeigt
Title: Kreuzreaktion mit dem Spike-Protein in allen getesteten Varianten des COVID-19-Virus gezeigt und besonders wirksame Ergebnisse gegen die hochansteckende Delta-Variante gezeigt
Search URL Search Domain Scan URL
URL: https://defencetherapeutics.com/wp-content/uploads/2021/05/Defence_press_release_May25_2021_AccuVAX-D001_Final-4.pdf
Title: Krebsimpfstoff AccuVAC-D001 von Defence Therapeutics eine sehr wirksame antitumorale Reaktion, die bei Mäusen eine Heilungsrate von 70 % zeigte
Title: Krebsimpfstoff AccuVAC-D001 von Defence Therapeutics eine sehr wirksame antitumorale Reaktion, die bei Mäusen eine Heilungsrate von 70 % zeigte
Search URL Search Domain Scan URL
URL: http://phrma-docs.phrma.org/sites/default/files/pdf/08-17-2010_economic_impact_study.pdf
Title: 1,5 % des globalen BIP entspricht
Title: 1,5 % des globalen BIP entspricht
Search URL Search Domain Scan URL
URL: https://www.alliedmarketresearch.com/biopharmaceutical-market
Title: bis 2025 auf 526 Mrd. USD steigen, mit einer geschätzten CAGR von 13,8 % von 2018 bis 2025
Title: bis 2025 auf 526 Mrd. USD steigen, mit einer geschätzten CAGR von 13,8 % von 2018 bis 2025
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-erreicht-wichtigen-meilenstein-und-beginnt-die-fuer-die-einholung-der-indzulassung-von-der-fda-erforderlichen-tests-seiner-accutoxleitsubstanz-gegen-brustkrebs/?newsID=1502009
Title: Defence Therapeutics erreicht wichtigen Meilenstein und beginnt die für die Einholung der IND-Zulassung von der FDA erforderlichen Tests seiner AccuTOX-Leitsubstanz gegen Brustkrebs
Title: Defence Therapeutics erreicht wichtigen Meilenstein und beginnt die für die Einholung der IND-Zulassung von der FDA erforderlichen Tests seiner AccuTOX-Leitsubstanz gegen Brustkrebs
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/impfstoffergebnisse-defence-therapeutics-gibt-erfolgreichen-abschluss-der-toxikologischen-studien-kaninchen-seinem-covidimpfstoff-accuvacpt-bekannt/?newsID=1484806
Title: Defence Therapeutics Inc.: Einleitung der Herstellung des Krebsimpfstoffs AccuVAC-D001 von Defence Therapeutics zur gezielten Bekämpfung von Melanomen und Brustkrebs
Title: Defence Therapeutics Inc.: Einleitung der Herstellung des Krebsimpfstoffs AccuVAC-D001 von Defence Therapeutics zur gezielten Bekämpfung von Melanomen und Brustkrebs
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/bei-einer-vitrostudie-erhoehen-die-accumtmvarianten-von-defence-therapeutics-die-wirksamkeit-des-antiwirkstoffkonjugats-adc-tderuxtecan-gegen-brustkrebs-das-fuenffache/?newsID=1481059
Title: Bei einer In Vitro-Studie erhöhen die Accum™-Varianten von Defence Therapeutics die Wirksamkeit des Anti-Wirkstoff-Konjugats (ADC) T-Deruxtecan gegen Brustkrebs um das Fünffache
Title: Bei einer In Vitro-Studie erhöhen die Accum™-Varianten von Defence Therapeutics die Wirksamkeit des Anti-Wirkstoff-Konjugats (ADC) T-Deruxtecan gegen Brustkrebs um das Fünffache
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-bereitet-sich-auf-phase-istudie-vor-seinen-dcimpfstoff-gegen-melanome-accuvacd-testen/?newsID=1479634
Title: Defence Therapeutics bereitet sich auf Phase I-Studie vor, um seinen DC-Impfstoff gegen Melanome, AccuVAC-D002, zu testen
Title: Defence Therapeutics bereitet sich auf Phase I-Studie vor, um seinen DC-Impfstoff gegen Melanome, AccuVAC-D002, zu testen
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-finalisiert-ihre-ziele-zum-start-einer-phaseistudie-gegen-brustkrebs/?newsID=1477977
Title: Defence Therapeutics finalisiert ihre Ziele zum Start einer Phase-I-Studie gegen Brustkrebs
Title: Defence Therapeutics finalisiert ihre Ziele zum Start einer Phase-I-Studie gegen Brustkrebs
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-meldet-den-erfolgreichen-verlauf-von-entwicklung-und-tests-einer-neuartigen-intranasalen-covidimpfstoffformulierung-tieren/?newsID=1476333
Title: Defence Therapeutics meldet den erfolgreichen Verlauf von Entwicklung und Tests einer neuartigen intranasalen COVID-19-Impfstoffformulierung an Tieren
Title: Defence Therapeutics meldet den erfolgreichen Verlauf von Entwicklung und Tests einer neuartigen intranasalen COVID-19-Impfstoffformulierung an Tieren
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-fuehrt-erfolgreiche-tests-seines-accuvacpt-impfstoffs-gegen-covid-einem-nichtnagetiermodell-durch/?newsID=1475486
Title: Defence Therapeutics führt erfolgreiche Tests seines AccuVAC-PT001- Impfstoffs gegen COVID-19 in einem Nicht-Nagetiermodell durch
Title: Defence Therapeutics führt erfolgreiche Tests seines AccuVAC-PT001- Impfstoffs gegen COVID-19 in einem Nicht-Nagetiermodell durch
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/start-eines-programms-von-defence-therapeutics-zur-entwicklung-eines-neuen-hpvimpfstoffs/?newsID=1474363
Title: Start eines Programms von Defence Therapeutics zur Entwicklung eines neuen HPV-Impfstoffs
Title: Start eines Programms von Defence Therapeutics zur Entwicklung eines neuen HPV-Impfstoffs
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-reicht-provisorische-uspatentanmeldung-fuer-saeurebasierte-hydrogele-ein/?newsID=1473099
Title: Defence Therapeutics reicht provisorische US-Patentanmeldung für säurebasierte Hydrogele ein
Title: Defence Therapeutics reicht provisorische US-Patentanmeldung für säurebasierte Hydrogele ein
Search URL Search Domain Scan URL
URL: https://www.healtheuropa.eu/defence-therapeutics-selects-new-variants-to-optimise-drug-delivery/110508/
Title: Defence Therapeutics selects new variants to optimise drug delivery
Title: Defence Therapeutics selects new variants to optimise drug delivery
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-waehlt-die-besten-accumtmvarianten-aus-seine-adctherapie-optimieren/?newsID=1470867
Title: Defence Therapeutics wählt die besten 8 Accum™-Varianten aus, um seine ADC-Therapie zu optimieren
Title: Defence Therapeutics wählt die besten 8 Accum™-Varianten aus, um seine ADC-Therapie zu optimieren
Search URL Search Domain Scan URL
URL: https://www.healtheuropa.eu/defence-therapeutics-transforming-drug-delivery-and-improving-treatment/109504/
Title: Defence Therapeutics: Transforming drug delivery and improving treatment
Title: Defence Therapeutics: Transforming drug delivery and improving treatment
Search URL Search Domain Scan URL
URL: https://www.finanznachrichten.de/nachrichten-2021-08/53592457-dgap-news-defence-therapeutics-inc-defence-therapeutics-unterzeichnet-eine-vereinbarung-mit-biopharma-excellence-um-die-entwicklung-seiner-accum-p-022.htm
Title: Defence Therapeutics unterzeichnet eine Vereinbarung mit Biopharma Excellence, einem Unternehmen der Pharmalex GmbH, um die Entwicklung seiner ACCUM™-Plattform und der klinischen Studien strategisch zu optimieren
Title: Defence Therapeutics unterzeichnet eine Vereinbarung mit Biopharma Excellence, einem Unternehmen der Pharmalex GmbH, um die Entwicklung seiner ACCUM™-Plattform und der klinischen Studien strategisch zu optimieren
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/die-durch-den-impfstoff-accuvacpt-von-defence-therapeutics-induzierte-antikoerperantwort-zeigt-eine-kreuzreaktion-mit-allen-getesteten-sarscovvarianten/?newsID=1461829
Title: Die durch den Impfstoff AccuVAC-PT100 von Defence Therapeutics induzierte Antikörperantwort zeigt eine Kreuzreaktion mit allen getesteten SARS-CoV-2-Varianten
Title: Die durch den Impfstoff AccuVAC-PT100 von Defence Therapeutics induzierte Antikörperantwort zeigt eine Kreuzreaktion mit allen getesteten SARS-CoV-2-Varianten
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-unterzeichnet-kooperationsvereinbarung-mit-dem-institut-curie-zum-testen-eines-accumtdm-adctherapeutikums-pdxbrustkrebsmodellen/?newsID=1459673
Title: Defence Therapeutics unterzeichnet Kooperationsvereinbarung mit dem Institut Curie zum Testen eines Accum-T-DM1 ADC-Therapeutikums in PDX-Brustkrebsmodellen
Title: Defence Therapeutics unterzeichnet Kooperationsvereinbarung mit dem Institut Curie zum Testen eines Accum-T-DM1 ADC-Therapeutikums in PDX-Brustkrebsmodellen
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-inc-accutox-von-defence-therapeutics-zeigt-potente-antikrebseigenschaften/?newsID=1457248
Title: AccuTOX von Defence Therapeutics zeigt potente Anti-Krebs-Eigenschaften
Title: AccuTOX von Defence Therapeutics zeigt potente Anti-Krebs-Eigenschaften
Search URL Search Domain Scan URL
URL: https://www.healtheuropa.eu/towards-a-cancer-revolution-with-new-targeted-therapeutics/108987/
Title: Health Europa: Towards a cancer revolution with new targeted therapeutics
Title: Health Europa: Towards a cancer revolution with new targeted therapeutics
Search URL Search Domain Scan URL
URL: https://www.healtheuropa.eu/defence-therapeutics-vaccine-against-cancer-makes-progress/109006/
Title: Health Europa: Defence therapeutics vaccine against cancer makes progress
Title: Health Europa: Defence therapeutics vaccine against cancer makes progress
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-inc-defence-therapeutics-beauftragt-das-hus-comprehensive-cancer-center-mit-der-optimierung-des-adctherapeutikums-accumtdm/?newsID=1452729
Title: Defence Therapeutics beauftragt das HUS Comprehensive Cancer Center mit der Optimierung des ADC-Therapeutikums Accum-T-DM1
Title: Defence Therapeutics beauftragt das HUS Comprehensive Cancer Center mit der Optimierung des ADC-Therapeutikums Accum-T-DM1
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-verzeichnet-fortschritte-bei-den-praeklinischen-tests-seines-impfprogramms-gegen-infektionskrankheiten/?newsID=1451070
Title: Defence Therapeutics Inc. verzeichnet Fortschritte bei den präklinischen Tests seines Impfprogramms gegen Infektionskrankheiten
Title: Defence Therapeutics Inc. verzeichnet Fortschritte bei den präklinischen Tests seines Impfprogramms gegen Infektionskrankheiten
Search URL Search Domain Scan URL
URL: https://www.dgap.de/dgap/News/corporate/defence-therapeutics-mit-starker-produktpipeline-antikoerperwirkstoffkonjugate-krebs-und-covidimpfstoffe/?newsID=1446465
Title: Defence Therapeutics mit starker Produktpipeline: Antikörper-Wirkstoff-Konjugate, Krebs- und Covid-Impfstoffe
Title: Defence Therapeutics mit starker Produktpipeline: Antikörper-Wirkstoff-Konjugate, Krebs- und Covid-Impfstoffe
Search URL Search Domain Scan URL
URL: https://defencetherapeutics.com/
Title: Homepage
Title: Homepage
Search URL Search Domain Scan URL
URL: https://www.irw-press.com/de/newsliste/txt/defence%2520therapeutics.html
Title: Pressemeldungen
Title: Pressemeldungen
Search URL Search Domain Scan URL
URL: https://www.wallstreet-online.de/aktien/defence-therapeutics-registered-a-aktie
Title: Börsenkurs (wallstreet-online.de)
Title: Börsenkurs (wallstreet-online.de)
Search URL Search Domain Scan URL
URL: https://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00050612
Title: SEDAR Profil
Title: SEDAR Profil
Search URL Search Domain Scan URL
URL: https://thecse.com/en/listings/life-sciences/defence-therapeutics-inc
Title: CSE Listing
Title: CSE Listing
Search URL Search Domain Scan URL
Page URL History
This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.
-
http://biopharma-stocks.com/
HTTP 301
https://www.biopharma-stocks.com/ Page URL
Redirected requests
There were HTTP redirect chains for the following requests:
Request Chain 76- https://googleads.g.doubleclick.net/pagead/id HTTP 302
- https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
- https://googleads.g.doubleclick.net/pagead/id HTTP 302
- https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
108 HTTP transactions
| Method Protocol |
Resource Path |
Size x-fer |
Type MIME-Type |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GET H/1.1 |
Primary Request
/
www.biopharma-stocks.com/ Redirect Chain
|
231 KB 26 KB |
Document
text/html |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
Redirect headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
style.min.css
www.biopharma-stocks.com/wp-includes/css/dist/block-library/ |
77 KB 78 KB |
Stylesheet
text/css |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
34a3b33d1ef29fa6171e2f8c71c6be47.min.css
www.biopharma-stocks.com/wp-content/uploads/fusion-styles/ |
1 MB 1 MB |
Stylesheet
text/css |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.min.js
www.biopharma-stocks.com/wp-includes/js/jquery/ |
87 KB 88 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery-migrate.min.js
www.biopharma-stocks.com/wp-includes/js/jquery/ |
11 KB 11 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
headline-white-1.png
www.biopharma-stocks.com/wp-content/uploads/2021/07/ |
5 KB 6 KB |
Image
image/png |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
Header.jpg
www.biopharma-stocks.com/wp-content/uploads/2021/07/ |
609 KB 609 KB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
wp-emoji-release.min.js
www.biopharma-stocks.com/wp-includes/js/ |
18 KB 18 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
labor-600x338.jpg
www.biopharma-stocks.com/wp-content/uploads/2021/08/ |
70 KB 70 KB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
cancer.jpg
www.biopharma-stocks.com/wp-content/uploads/2021/08/ |
3 MB 3 MB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
cell-target-600x405.jpg
www.biopharma-stocks.com/wp-content/uploads/2021/08/ |
79 KB 79 KB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
cssua.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
3 KB 4 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-animations.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-vertical-menu-widget.js
www.biopharma-stocks.com/wp-content/plugins/fusion-core/js/min/ |
1 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
modernizr.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
13 KB 13 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
4 KB 5 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
bootstrap.transition.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
741 B 1001 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
bootstrap.tooltip.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
11 KB 11 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.requestAnimationFrame.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
695 B 955 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.easing.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.fitvids.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.flexslider.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
22 KB 22 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.ilightbox.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
81 KB 81 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.mousewheel.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
3 KB 3 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.placeholder.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.fade.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
1 KB 1 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-equal-heights.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
1 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-parallax.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
12 KB 12 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-video-general.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
3 KB 4 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-video-bg.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
4 KB 5 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-lightbox.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
7 KB 7 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-tooltip.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
849 B 1 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-sharing-box.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
945 B 1 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
jquery.sticky-kit.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
6 KB 6 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-youtube.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
4 KB 4 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
vimeoPlayer.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/library/ |
16 KB 16 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-general-footer.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
413 B 673 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-quantity.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-crossfade-images.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
418 B 678 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-select.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
886 B 1 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-tabs-widget.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
503 B 763 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-live-search.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
3 KB 3 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-alert.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
260 B 520 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
awb-off-canvas.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
10 KB 10 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-flexslider.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
6 KB 7 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
lite-yt-embed.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/library/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-container.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
15 KB 16 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-content-boxes.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
4 KB 4 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-drop-down.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
6 KB 6 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-to-top.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
1017 B 1 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-header.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
31 KB 32 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-menu.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
39 KB 39 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
bootstrap.scrollspy.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/library/ |
3 KB 3 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
avada-scrollspy.js
www.biopharma-stocks.com/wp-content/themes/Avada/assets/min/js/general/ |
729 B 989 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-responsive-typography.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
3 KB 4 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-scroll-to-anchor.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
5 KB 6 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-general-global.js
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/min/js/general/ |
496 B 756 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-video.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
2 KB 2 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fusion-column.js
www.biopharma-stocks.com/wp-content/plugins/fusion-builder/assets/js/min/general/ |
666 B 926 B |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
gtm.js
www.googletagmanager.com/ |
85 KB 33 KB |
Script
application/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
Yqekde-I61o
www.youtube.com/embed/ Frame 32BC |
59 KB 25 KB |
Document
text/html |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
fonts.gstatic.com/s/opensans/v27/ |
44 KB 44 KB |
Font
font/woff2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
awb-icons.woff
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/fonts/icomoon/ |
19 KB 19 KB |
Font
application/font-woff |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
dFa6ZfeM_74wlPZtksIFajo6_Q.woff2
fonts.gstatic.com/s/zillaslab/v6/ |
23 KB 23 KB |
Font
font/woff2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
fa-solid-900.woff2
www.biopharma-stocks.com/wp-content/themes/Avada/includes/lib/assets/fonts/fontawesome/webfonts/ |
76 KB 77 KB |
Font
application/font-woff2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
www-player-webp.css
www.youtube.com/s/player/e06dea74/ Frame 32BC |
340 KB 47 KB |
Stylesheet
text/css |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
www-embed-player.js
www.youtube.com/s/player/e06dea74/www-embed-player.vflset/ Frame 32BC |
274 KB 84 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
base.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame 32BC |
2 MB 535 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
fetch-polyfill.js
www.youtube.com/s/player/e06dea74/fetch-polyfill.vflset/ Frame 32BC |
8 KB 3 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 32BC |
15 KB 15 KB |
Font
font/woff2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
js
www.googletagmanager.com/gtag/ |
167 KB 61 KB |
Script
application/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
obtp.js
amplify.outbrain.com/cp/ |
8 KB 3 KB |
Script
application/x-javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
POST H2 |
collect
analytics.google.com/g/ |
0 353 B |
Ping
text/plain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
POST H2 |
collect
stats.g.doubleclick.net/g/ |
0 353 B |
Ping
text/plain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
ga-audiences
www.google.de/ads/ |
42 B 501 B |
Image
image/gif |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
cachedClickId
tr.outbrain.com/ |
35 B 239 B |
Script
application/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H/1.1 |
unifiedPixel
tr.outbrain.com/ |
43 B 256 B |
Image
image/gif |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
id
googleads.g.doubleclick.net/pagead/ Frame 32BC Redirect Chain
|
100 B 146 B |
XHR
application/json |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
Redirect headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
ad_status.js
static.doubleclick.net/instream/ Frame 32BC |
29 B 588 B |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
remote.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame 32BC |
97 KB 30 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
M7SGa8U2pc4ScmJa8ZDN-KnMzqRdkli8RSo5HcCAB98.js
www.google.com/js/th/ Frame 32BC |
35 KB 14 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
embed.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame 32BC |
26 KB 7 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET DATA |
truncated
/ Frame 32BC |
175 B 0 |
Image
image/png |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
AKedOLSt9TvCETQM1-5j8ZWPqS8yrXjxsIsfutnDD1RH=s68-c-k-c0x00ffffff-no-rj
yt3.ggpht.com/ytc/ Frame 32BC |
1 KB 2 KB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
sddefault.webp
i.ytimg.com/vi_webp/Yqekde-I61o/ Frame 32BC |
32 KB 33 KB |
Image
image/webp |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H2 |
cast_sender.js
www.gstatic.com/cv/js/sender/v1/ Frame 32BC |
4 KB 3 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
generate_204
www.youtube.com/ Frame 32BC |
0 9 B |
Image
text/plain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
cast_sender.js
www.gstatic.com/eureka/clank/97/ Frame 32BC |
53 KB 15 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
POST |
atr
www.youtube.com/api/stats/ Frame 32BC |
0 0 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET |
Yqekde-I61o
www.youtube.com/embed/ Frame E63C |
0 0 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
Yqekde-I61o
www.youtube.com/embed/ Frame E63C |
59 KB 24 KB |
Document
text/html |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
iframe_api
www.youtube.com/ |
980 B 513 B |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
www-widgetapi.js
www.youtube.com/s/player/e06dea74/www-widgetapi.vflset/ |
146 KB 47 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
www-player-webp.css
www.youtube.com/s/player/e06dea74/ Frame E63C |
340 KB 47 KB |
Stylesheet
text/css |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
www-embed-player.js
www.youtube.com/s/player/e06dea74/www-embed-player.vflset/ Frame E63C |
274 KB 84 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
base.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame E63C |
2 MB 535 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
fetch-polyfill.js
www.youtube.com/s/player/e06dea74/fetch-polyfill.vflset/ Frame E63C |
8 KB 3 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame E63C |
15 KB 15 KB |
Font
font/woff2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
id
googleads.g.doubleclick.net/pagead/ Frame E63C Redirect Chain
|
100 B 146 B |
XHR
application/json |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
Redirect headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
ad_status.js
static.doubleclick.net/instream/ Frame E63C |
29 B 54 B |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
remote.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame E63C |
97 KB 30 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
M7SGa8U2pc4ScmJa8ZDN-KnMzqRdkli8RSo5HcCAB98.js
www.google.com/js/th/ Frame E63C |
35 KB 13 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
embed.js
www.youtube.com/s/player/e06dea74/player_ias.vflset/de_DE/ Frame E63C |
26 KB 7 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET DATA |
truncated
/ Frame E63C |
175 B 0 |
Image
image/png |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
AKedOLSt9TvCETQM1-5j8ZWPqS8yrXjxsIsfutnDD1RH=s68-c-k-c0x00ffffff-no-rj
yt3.ggpht.com/ytc/ Frame E63C |
1 KB 2 KB |
Image
image/jpeg |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
sddefault.webp
i.ytimg.com/vi_webp/Yqekde-I61o/ Frame E63C |
32 KB 32 KB |
Image
image/webp |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
cast_sender.js
www.gstatic.com/cv/js/sender/v1/ Frame E63C |
4 KB 2 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
generate_204
www.youtube.com/ Frame E63C |
0 9 B |
Image
text/plain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GET H3 |
cast_sender.js
www.gstatic.com/eureka/clank/97/ Frame E63C |
53 KB 15 KB |
Script
text/javascript |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
POST H3 |
log_event
www.youtube.com/youtubei/v1/ Frame E63C |
28 B 54 B |
XHR
application/json |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General
Request headers
Response headers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Failed requests
These URLs were requested, but there was no response received. You will also see them in the list above.
- Domain
- www.youtube.com
- URL
- https://www.youtube.com/api/stats/atr?ns=yt&el=embedded&cpn=zE6HcVYr15SX83uG&ver=2&cmt=0&fs=0&rt=0&euri=https%3A%2F%2Fwww.biopharma-stocks.com%2F&lact=529&cl=425237549&mos=0&volume=100&cbr=Chrome&cbrver=97.0.4692.71&c=WEB_EMBEDDED_PLAYER&cver=1.20220130.00.00&cplayer=UNIPLAYER&cos=Windows&cosver=10.0&cplatform=DESKTOP&hl=de_DE&cr=DE&len=143&fexp=23983296%2C24001373%2C24002022%2C24002025%2C24002923%2C24004644%2C24007246%2C24080738%2C24082661%2C24126631%2C24129402%2C24135310%2C24146770%2C24158010&muted=0&vis=3&docid=Yqekde-I61o
- Domain
- www.youtube.com
- URL
- https://www.youtube.com/embed/Yqekde-I61o?wmode=transparent&autoplay=0
Verdicts & Comments Add Verdict or Comment
133 JavaScript Global Variables
These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.
object| 0 object| _wpemojiSettings undefined| $ function| jQuery object| doc object| dataLayer function| fusionNavIsCollapsed function| fusionRunNavIsCollapsed function| avadaGetScrollBarWidth object| cssua object| fusionAnimationsVars function| fusionSetAnimationData object| awbAnimationObservers object| Modernizr object| fusionJSVars object| fusion object| google_tag_manager function| obApi object| google_tag_data object| gaGlobal object| fusionLightboxVideoVars object| browserPrefixes object| fusionEqualHeightVars function| _fusionRefreshScroll function| _fusionParallaxAll function| _fusionRefreshWindow object| _fusionImageParallaxImages object| fusionVideoGeneralVars function| playVideoAndPauseOthers object| fusionVideoBgVars object| $youtubeBGVideos function| _fbRowGetAllElementsWithAttribute function| _fbRowOnPlayerReady function| _fbRowOnPlayerStateChange function| resizeVideo function| vimeoReady function| fusionInitVimeoPlayers object| fusionLightboxVars function| avadaLightBoxInitializeLightbox object| avadaLightBox object| $ilInstances function| fusionInitTooltips undefined| prevCallback object| fusionTimeout function| registerYoutubePlayers function| onPlayerReady function| loadYoutubeIframeAPI function| onYouTubePlayerAPIReadyCallback function| onPlayerStateChange function| ytVidId function| insertParam function| fusionYouTubeTimeout function| onYouTubeIframeAPIReady function| onYouTubePlayerAPIReady function| YTReady object| Vimeo boolean| VimeoPlayerResizeEmbeds_ function| avadaAddQuantityBoxes function| compositeAddQuantityBoxes function| fusionResizeCrossfadeImagesContainer function| calcSelectArrowDimensions object| avadaLiveSearchVars function| avadaLiveSearch object| awbOffCanvas object| fusionFlexSliderVars function| fusionInitPostFlexSlider function| fusionDestroyPostFlexSlider object| fusionContainerVars function| fusionInitStickyContainers function| fusionInitSticky function| fusionGetStickyOffset function| initScrollingSections function| setCorrectResizeValuesForScrollSections function| scrollToCurrentScrollSection function| getScrollSectionPositionValues object| avadaSelectVars function| addAvadaSelectStyles function| removeAvadaSelectStyles object| avadaToTopVars function| avadaUpdateToTopPostion object| avadaHeaderVars function| fusionDisableStickyHeader function| fusionInitStickyHeader function| getStickyHeaderHeight object| avadaMenuVars function| resizeOverlaySearch function| fusionGetScrollOffset object| fusionTypographyVars function| fusionCalculateResponsiveTypeValues function| fusionSetOriginalTypographyData function| fusionInitTypography object| fusionScrollToAnchorVars function| checkHoverTouchState object| fusionVideoVars string| responsiveTypeElements boolean| yt_vid_exists object| $youtube_players number| lastYPosition boolean| scrollDisabled number| _fusionScrollTop number| _fusionWindowHeight number| _fusionScrollLeft number| _fusionWindowWidth object| twemoji object| wp object| scriptUrl object| ttPolicy object| YT object| YTConfig function| onYTReady object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter object| ytPubsubPubsubInstance object| ytPubsubPubsubTopicToKeys object| ytPubsubPubsubIsSynchronous object| ytPubsubPubsubSubscribedKeys object| ytLoggingTransportGELQueue_ object| ytLoggingTransportGELProtoQueue_ object| ytLoggingTransportTokensToCttTargetIds_ object| ytLoggingTransportTokensToJspbCttTargetIds_ object| ytLoggingGelSequenceIdObj_ object| ytglobal object| ytPubsub2Pubsub2Instance object| ytPubsub2Pubsub2SubscribedKeys object| ytPubsub2Pubsub2TopicToKeys object| ytPubsub2Pubsub2IsAsync object| ytPubsub2Pubsub2SkipSubKey object| ytNetworklessLoggingInitializationOptions object| php_js object| fusionVimeoPlayers boolean| mobileMenuSepAdded6 Cookies
Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.
| Domain/Path | Expires | Name / Value |
|---|---|---|
| www.biopharma-stocks.com/ | Name: SERVERID Value: app1inst6 |
|
| .youtube.com/ | Name: YSC Value: aKsmYzW5luU |
|
| .youtube.com/ | Name: VISITOR_INFO1_LIVE Value: MJXmmX7br7w |
|
| .biopharma-stocks.com/ | Name: _ga_G3GEFXXBTP Value: GS1.1.1643710299.1.0.1643710299.60 |
|
| .biopharma-stocks.com/ | Name: _ga Value: GA1.1.484131057.1643710299 |
|
| www.biopharma-stocks.com/ | Name: outbrain_cid_fetch Value: true |
3 Console Messages
A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.
| Source | Level | URL Text |
|---|
Security Headers
This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page
| Header | Value |
|---|---|
| X-Xss-Protection | 1; mode=block |
Indicators
This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.
amplify.outbrain.com
analytics.google.com
biopharma-stocks.com
fonts.gstatic.com
googleads.g.doubleclick.net
i.ytimg.com
static.doubleclick.net
stats.g.doubleclick.net
tr.outbrain.com
www.biopharma-stocks.com
www.google.com
www.google.de
www.googletagmanager.com
www.gstatic.com
www.youtube.com
yt3.ggpht.com
www.youtube.com
184.30.21.80
185.17.252.199
2a00:1450:4001:801::2016
2a00:1450:4001:802::2003
2a00:1450:4001:803::2006
2a00:1450:4001:80e::2004
2a00:1450:4001:810::2003
2a00:1450:4001:812::2002
2a00:1450:4001:82a::200e
2a00:1450:4001:82b::2003
2a00:1450:4001:82f::2008
2a00:1450:4001:830::200e
2a00:1450:4001:831::2001
2a00:1450:400c:c08::9c
70.42.32.63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